News and Analysis

Walden Biosciences takes in $51m Series A

Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing.

-

Cambridge, Massachusetts-based Walden Biosciences Inc, a biotech company focused on treating kidney disease, has raised $51 million in Series A financing. ARCH Venture Partners and UCB Ventures led the round.

Source: Press Release